Opioid decisions backed by objective response
Taper, hold, or escalate with objective response data behind the decision, and a documented trail that stands up to scrutiny instead of resting on a 0-to-10 question.
Bardel adds reimbursable remote therapeutic monitoring to your practice with zero extra staff, and gives you objective response data behind every treatment and every opioid decision.
Between visits, the most important question in your practice goes dark. You judge what is working from a patient's recall, and the monitoring you could be billing for keeps failing the documentation it needs to get paid.
Treatment decisions ride on a patient's recall of recent months, not objective data on how their body responded.
No objective read on the response exists between visits, so every taper, hold, or escalation comes down to a judgment call.
Remote-monitoring claims routinely fail documentation audits when there is no objective response data behind them.
Trak+ captures the physiological signal others miss from the devices your patients already carry, turns it into an objective treatment-response read, and documents the monitoring as billable care from the first session.
From a phone camera, a watch, or a chest strap your patient already owns. No new hardware to dispense.
The body's response to each dose, in real time, between visits. The structure of the signal, not just its volume.
The right treatment to the response, dose by dose, with a clear read for every patient on your panel.
Monitoring becomes reimbursable RTM revenue from day one, with a complete audit trail behind every claim.
Every session compounds into a panel-wide picture that gets sharper the longer you use it.
Strong responder, moderate, non-responder, or adverse.
Taper, hold, or escalate with objective response data behind the decision, and a documented trail that stands up to scrutiny instead of resting on a 0-to-10 question.
Follow how patients are responding to therapy between appointments, so symptom changes surface as data rather than as a phone call after the fact.
An objective read on how patients respond to treatment over time, supporting your clinical decisions across pain, oncology, behavioral health, and research.
Remote therapeutic monitoring is reimbursable today. Bardel turns it into a new line of practice revenue you can bill from the first session, with the complete documentation trail the claim needs to get paid.
Revenue from day one
Remote therapeutic monitoring is billable from the first session, with no added staff and no new hardware to dispense. The monitoring you already wish you had becomes a line of revenue, captured and documented automatically.
Scales with your panel
Every patient you enroll runs on the same workflow, so the billable monitoring grows with your panel, not your overhead. Across the platform, Bardel has already captured 850+ therapeutic sessions across 33 states, as of 2026.
Objective response data for every dose and every opioid decision, plus a complete audit trail. You stop reconstructing the last three months from a conversation and start reading what actually happened.
One platform configured for pain, oncology, behavioral health, and research, so the same objective response read works for every patient you treat.
No new device to dispense and no new screen to learn. The objective response read sits next to the patient you are already seeing, on the phone, watch, or chest strap they already carry, so the data is there the moment you need to decide.
Bardel's clinical program is advised by Dr. Brian Shaffer, who brings more than 40 years in pain medicine as founder of Princeton Pain Management. The platform is built to put objective treatment-response data behind the decisions clinicians make every day, including the hardest opioid calls.
See the clinician dashboard, the per-dose response reads, and how the reimbursable monitoring works, in a short live walkthrough.